A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

PHASE4RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 29, 2029

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Belimumab (GSK1550188)

GSK1550188 will be administered subcutaneously.

Trial Locations (100)

1425

RECRUITING

GSK Investigational Site, Ciudad Autonoma de Buenos Aire

1884

RECRUITING

GSK Investigational Site, Berazategui

3570

RECRUITING

GSK Investigational Site, Villajoyosa

7600

RECRUITING

GSK Investigational Site, Mar del Plata

11527

RECRUITING

GSK Investigational Site, Athens

12462

RECRUITING

GSK Investigational Site, Athens

14004

RECRUITING

GSK Investigational Site, Córdoba

16635

RECRUITING

GSK Investigational Site, Duncansville

19140

RECRUITING

GSK Investigational Site, Philadelphia

20089

RECRUITING

GSK Investigational Site, Rozzano

23538

RECRUITING

GSK Investigational Site, Lübeck

24541

RECRUITING

GSK Investigational Site, Danville

25123

RECRUITING

GSK Investigational Site, Brescia

28207

RECRUITING

GSK Investigational Site, Charlotte

30120

RECRUITING

GSK Investigational Site, Murcia

30152

RECRUITING

GSK Investigational Site, Atlanta

30518

WITHDRAWN

GSK Investigational Site, Sugar Hill

31400

RECRUITING

GSK Investigational Site, Toulouse

33126

WITHDRAWN

GSK Investigational Site, Miami

33180

RECRUITING

GSK Investigational Site, Aventura

33321

RECRUITING

GSK Investigational Site, Tamarac

33604

RECRUITING

GSK Investigational Site, Pessac

33606

RECRUITING

GSK Investigational Site, Tampa

33765

RECRUITING

GSK Investigational Site, Clearwater

35200

RECRUITING

GSK Investigational Site, Rennes

36207

RECRUITING

GSK Investigational Site, Anniston

36213

RECRUITING

GSK Investigational Site, VigoPontevedra

37000

RECRUITING

GSK Investigational Site, León

40668

RECRUITING

GSK Investigational Site, Meerbusch

41014

RECRUITING

GSK Investigational Site, Seville

42123

RECRUITING

GSK Investigational Site, Reggio Emilia

42270

RECRUITING

GSK Investigational Site, Saint-Priest-en-Jarez

44124

RECRUITING

GSK Investigational Site, Ferrara

44649

RECRUITING

GSK Investigational Site, Herne

47012

RECRUITING

GSK Investigational Site, Valladolid

48910

RECRUITING

GSK Investigational Site, Lansing

49933

RECRUITING

GSK Investigational Site, Angers

53217

RECRUITING

GSK Investigational Site, Glendale

54642

RECRUITING

GSK Investigational Site, Thessaloniki

55131

RECRUITING

GSK Investigational Site, Mainz

RECRUITING

GSK Investigational Site, Mainz

56100

RECRUITING

GSK Investigational Site, Pisa

59800

RECRUITING

GSK Investigational Site, Lille

60123

RECRUITING

GSK Investigational Site, Rockford

60521

RECRUITING

GSK Investigational Site, Morton Grove

64000

RECRUITING

GSK Investigational Site, Monterrey Nuevo LeOn

70836

RECRUITING

GSK Investigational Site, Baton Rouge

71115

RECRUITING

GSK Investigational Site, Shreveport

71500

RECRUITING

GSK Investigational Site, Heraklion

75024

RECRUITING

GSK Investigational Site, Plano

76034

RECRUITING

GSK Investigational Site, Colleyville

76109

RECRUITING

GSK Investigational Site, Fort Worth

76710

WITHDRAWN

GSK Investigational Site, Waco

77089

RECRUITING

GSK Investigational Site, Houston

77494

RECRUITING

GSK Investigational Site, Katy

77521

RECRUITING

GSK Investigational Site, Baytown

78745

RECRUITING

GSK Investigational Site, Austin

85210

RECRUITING

GSK Investigational Site, Mesa

85748

RECRUITING

GSK Investigational Site, Tucson

86001

RECRUITING

GSK Investigational Site, Flagstaff

90211

RECRUITING

GSK Investigational Site, Los Angeles

90602

RECRUITING

GSK Investigational Site, Whittier

90720

RECRUITING

GSK Investigational Site, Long Beach

91042

RECRUITING

GSK Investigational Site, Tujunga

91345

RECRUITING

GSK Investigational Site, Mission Hills

91722

RECRUITING

GSK Investigational Site, Covina

92128

RECRUITING

GSK Investigational Site, San Diego

92335

RECRUITING

GSK Investigational Site, Fontana

92586

RECRUITING

GSK Investigational Site, Van Nuys

92835

RECRUITING

GSK Investigational Site, Fullerton

97000

RECRUITING

GSK Investigational Site, Mérida

92307-2333

RECRUITING

GSK Investigational Site, Van Nuys

07871

RECRUITING

GSK Investigational Site, Sparta

C1121ABE

RECRUITING

GSK Investigational Site, Buenos Aires

C1406AGA

RECRUITING

GSK Investigational Site, Buenos Aires

C1015ABO

RECRUITING

GSK Investigational Site, Ciudad Autonoma Buenos Aires

B1900AX

RECRUITING

GSK Investigational Site, La Plata

B1878GEG

RECRUITING

GSK Investigational Site, Quilmes

CP 4000

RECRUITING

GSK Investigational Site, San Miguel de Tucumán

S2000DSV

RECRUITING

GSK Investigational Site, Santa Fe

30150-221.

RECRUITING

GSK Investigational Site, Belo Horizonte

78020-840

RECRUITING

GSK Investigational Site, Cuiabá

36010-570

RECRUITING

GSK Investigational Site, Juiz de Fora

99010-080

RECRUITING

GSK Investigational Site, Passo Fundo

90035-001

RECRUITING

GSK Investigational Site, Porto Alegre

90430-001

RECRUITING

GSK Investigational Site, Porto Alegre

90610-000

RECRUITING

GSK Investigational Site, Porto Alegre

41820-020

RECRUITING

GSK Investigational Site, Salvador

15090-000

RECRUITING

GSK Investigational Site, São José do Rio Preto

01323-001

RECRUITING

GSK Investigational Site, São Paulo

05403-000

RECRUITING

GSK Investigational Site, São Paulo

11 527

RECRUITING

GSK Investigational Site, Athens

00168

RECRUITING

GSK Investigational Site, Rome

807-8556

RECRUITING

GSK Investigational Site, Fukuoka

252-0375

RECRUITING

GSK Investigational Site, Kanagawa

980-8574

RECRUITING

GSK Investigational Site, Miyagi

589-8511

RECRUITING

GSK Investigational Site, Osaka

104-8560

RECRUITING

GSK Investigational Site, Tokyo

06700

RECRUITING

GSK Investigational Site, Mexico City

08003

RECRUITING

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT06411249 - A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | Biotech Hunter | Biotech Hunter